SEC Filing Document

Company: BIOVENTRIX, INC.
Ticker: 
CIK: 1283259
Filing Type: S-1
Document Type: EX-3.1
Date Filed: 2026-02-12
Accession Number: 0001493152-26-006407
Exchange: 
SIC Code: 3841
SIC Description: Surgical & Medical Instruments & Apparatus
URL: https://www.sec.gov/Archives/edgar/data/1283259/000149315226006407/ex3-1.htm

Chunk 9 of 11
Word Count: 1358
Character Count: 8448

Document Content:

a holder of shares in certificated form, surrender the certificate or certificates representing such shares (or, if such registered holder alleges that such certificate has been lost, stolen or destroyed, a lost certificate affidavit and agreement reasonably acceptable to the Corporation to indemnify the Corporation against any claim that may be made against the Corporation on account of the alleged loss, theft or destruction of such certificate) to the Corporation, in the manner and at the place designated in the Redemption Notice, and thereupon the Redemption Price for such shares shall be payable to the order of the person whose name appears on such certificate or certificates as the owner thereof. In the event less than all of the shares of Preferred Stock represented by a certificate are redeemed, a new certificate, instrument, or book entry representing the unredeemed shares of Preferred Stock shall promptly be issued to such holder.

Interest. If any shares of Preferred Stock are not redeemed for any reason on any Redemption Date, all such unredeemed shares
shall remain outstanding and entitled to all the rights and preferences provided herein, and the Corporation shall pay interest on the
Redemption Price applicable to such unredeemed shares at an aggregate per annum rate equal to nine percent (9%) (increased by one percent
(1%) each month following the Redemption Date until the Redemption Price, and any interest thereon, is paid in full), with such interest
to accrue daily in arrears and be compounded annually; provided, however, that in no event shall such interest exceed the
maximum permitted rate of interest under applicable law (the “Maximum Permitted Rate”), provided, however,
that the Corporation shall take all such actions as may be necessary, including, without limitation, making any applicable governmental
filings, to cause the Maximum Permitted Rate to be the highest possible rate. In the event any provision hereof would result in the rate
of interest payable hereunder being in excess of the Maximum Permitted Rate, the amount of interest required to be paid hereunder shall
automatically be reduced to eliminate such excess; provided, however, that any subsequent increase in the Maximum Permitted
Rate shall be retroactively effective to the applicable Redemption Date to the extent permitted by law.

Rights Subsequent to Redemption. If the Redemption Notice shall have been duly given, and if on the applicable Redemption Date
the Redemption Price payable upon redemption of the shares of Preferred Stock to be redeemed on such Redemption Date is paid or tendered
for payment or deposited with an independent payment agent so as to be available therefor in a timely manner, then notwithstanding that
any certificates evidencing any of the shares of Preferred Stock so called for redemption shall not have been surrendered, dividends
with respect to such shares of Preferred Stock shall cease to accrue after such Redemption Date and all rights with respect to such shares
shall forthwith after the Redemption Date terminate, except only the right of the holders to receive the Redemption Price without interest
upon surrender of any such certificate or certificates therefor.

Redeemed or Otherwise Acquired Shares. Any shares of Preferred Stock that are redeemed, converted or otherwise acquired by the
Corporation or any of its subsidiaries shall be automatically and immediately cancelled and retired and shall not be reissued, sold or
transferred. Neither the Corporation nor any of its subsidiaries may exercise any voting or other rights granted to the holders of Preferred
Stock following redemption, conversion or acquisition.

Waiver. Except as otherwise set forth herein, (a) any of the rights, powers, preferences and other terms of the Preferred Stock
set forth herein may be waived on behalf of all holders of Preferred Stock by the affirmative written consent or vote of the holders
of at least 60% of the shares of Preferred Stock then outstanding and (b) at any time more than one (1) series of Preferred Stock is
issued and outstanding, any of the rights, powers, preferences and other terms of any series of Preferred Stock set forth herein may
be waived on behalf of all holders of such series of Preferred Stock by the affirmative written consent or vote of the holders of at
least 60% of the shares of such series of Preferred Stock then outstanding.

Notices. Any notice required or permitted by the provisions of this Article Fourth to be given to a holder of shares of Preferred
Stock shall be mailed, postage prepaid, to the post office address last shown on the records of the Corporation, or given by electronic
communication in compliance with the provisions of the General Corporation Law, and shall be deemed sent upon such mailing or electronic
transmission.

Fifth:
Subject to any additional vote required by this Third Amended and Restated Certificate of Incorporation or Bylaws, in furtherance and
not in limitation of the powers conferred by statute, the Board of Directors is expressly authorized to make, repeal, alter, amend and
rescind any or all of the Bylaws of the Corporation.

Sixth:
Subject to any additional vote required by this Third Amended and Restated Certificate of Incorporation, the number of directors of the
Corporation shall be determined in the manner set forth in the Bylaws of the Corporation. Each director shall be entitled to one (1)
vote on each matter presented to the Board of Directors; provided, however, that, so long as the holders of Preferred Stock
are entitled to elect a Preferred Director, the affirmative vote of at least one (1) Preferred Director shall be required for the authorization
by the Board of Directors of any of the matters set forth in Section 5.4 of the Investors’ Rights Agreement, dated as of
March 30, 2023, by and among the Corporation and the other parties thereto, as such agreement may be amended from time to time.

Seventh:
Elections of directors need not be by written ballot unless the Bylaws of the Corporation shall so provide.

Eighth:
Meetings of stockholders may be held within or without the State of Delaware, as the Bylaws of the Corporation may provide. The books
of the Corporation may be kept outside the State of Delaware at such place or places as may be designated from time to time by the Board
of Directors or in the Bylaws of the Corporation.

Ninth:
To the fullest extent permitted by law, a director of the Corporation shall not be personally liable to the Corporation or its stockholders
for monetary damages for breach of fiduciary duty as a director. If the General Corporation Law or any other law of the State of Delaware
is amended after approval by the stockholders of this Article Ninth to authorize corporate action further eliminating or limiting the
personal liability of directors, then the liability of a director of the Corporation shall be eliminated or limited to the fullest extent
permitted by the General Corporation Law as so amended.

Any
repeal or modification of the foregoing provisions of this Article Ninth by the stockholders of the Corporation shall not adversely affect
any right or protection of a director of the Corporation existing at the time of, or increase the liability of any director of the Corporation
with respect to any acts or omissions of such director occurring prior to, such repeal or modification.

Tenth:
To the fullest extent permitted by applicable law, the Corporation is authorized to provide indemnification of (and advancement of expenses
to) directors, officers and agents of the Corporation (and any other persons to which General Corporation Law permits the Corporation
to provide indemnification) through Bylaw provisions, agreements with such agents or other persons, vote of stockholders or disinterested
directors or otherwise, in excess of the indemnification and advancement otherwise permitted by Section 145 of the General Corporation
Law.

Any
amendment, repeal or modification of the foregoing provisions of this Article Tenth shall not (a) adversely affect any right or protection
of any director, officer or other agent of the Corporation existing at the time of such amendment, repeal or modification or (b) increase
the liability of any director of the Corporation with respect to any acts or omissions of such director, officer or agent occurring prior
to, such amendment, repeal or modification.